BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE)
CUSIP: 07782B104
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary Shares, par value US$0.0001 per share
- Shares outstanding
- 37,379,062
- Total 13F shares
- 78,699
- Share change
- -107,869
- Total reported value
- $3,689,407
- Price per share
- $46.88
- Number of holders
- 15
- Value change
- -$4,872,726
- Number of buys
- 11
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 07782B104?
CUSIP 07782B104 identifies BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 07782B104:
Top shareholders of BLTE - BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.4%
|
148,000
|
$6,760,640 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
15,671
|
$715,851 | — | 30 Jun 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.02%
|
7,311
|
$333,966 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
6,700
|
$306,056 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.01%
|
5,409
|
$247,000 | — | 30 Jun 2024 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0%
|
1,807
|
$82,544 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,044
|
$47,690 | — | 30 Jun 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
428
|
$19,551 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
102
|
$4,659 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
88
|
$4,020 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
8
|
$365 | — | 30 Jun 2024 |
Institutional Holders of BELITE BIO, INC - Ordinary Shares, par value US$0.0001 per share (BLTE) as of Q3 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.